# Study of HC-58 in Upper Limb Hemiplegic Patients After Stroke

> **NCT01623622** · PHASE2 · COMPLETED · sponsor: **Asahi Kasei Therapeutics Corporation** · enrollment: 270 (estimated)

## Conditions studied

- Severe Upper Limb Hemiplegia

## Interventions

- **DRUG:** HC-58
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01623622
- **Lead sponsor:** Asahi Kasei Therapeutics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2017-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01623622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01623622, "Study of HC-58 in Upper Limb Hemiplegic Patients After Stroke". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01623622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*